RF vs ROIV
RF (RF) versus Roivant Sciences Ltd (ROIV) — a side-by-side from cached financials, not a winner call.
RF (RF) common stock.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
RF does not have a complete income-statement cache yet.
Latest reported ROIV revenue for 2025-03-31 was $29.1M. Net income was -$356.7M. Revenue was down 11.2% from 2024-03-31 to 2025-03-31. ROIV currently screens at market cap $7.47B.
RF currently screens at market cap $0. ROIV currently screens at market cap $7.47B.
Not investment advice. Open the RF and ROIV stock pages for the full models.
Not investment advice.